VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) — Canfor Corporation (the “Company” or “Canfor”) (TSX: CFP) today reported its first quarter of 2026 results: Overview.For the first quarter of 2026, the Company reported an operating loss of $73 million and shareholder net loss of $72 million, equivalent to $0.62 per share. After taking into consideration adjusting items1 of $20 million, the adjusted operating loss for Q1 2026 was $93 million, compared to an adjusted operating loss of $145 million in Q4 2025. Global lumber markets remained challenging throughout Q1 2026, largely reflecting relatively subdued demand and ongoing trade and geopolitical pressures; however, periods of supply tightness contributed to some improvement in North American benchmark lumber pricing. Global softwood pulp markets remained weak through...

DALLAS, May 06, 2026 (GLOBE NEWSWIRE) — ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced the appointment of Cenly Chen as Chief Executive Officer and a member of the Company’s Board of Directors. Ms. Chen brings more than two decades of experience scaling enterprise infrastructure and high-performance computing platforms in global markets. She most recently served as Chief Growth Officer, Senior Vice President & Managing Director at Super Micro Computer, Inc. (Nasdaq: SMCI), where she led global growth initiatives across AI and enterprise infrastructure markets. “We believe the market is shifting from access to execution, and we built ChronoScale for that shift,” said Wes Cummins, Chairman of the Board of ChronoScale...

$60M Patent-Protected AI Platform Targets Edge-Native Autonomous Surveillance, Counter-UAS, and the Emerging “Persistent Digital Sentinel” Defense Category WEST HOLLYWOOD, Calif., May 06, 2026 (GLOBE NEWSWIRE) — VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a defense and advanced sensing technology company developing AI-driven, RF-based sensing, autonomy, and computational acceleration technologies for defense, homeland security, and commercial infrastructure applications, today announced its strategic roadmap to operationalize xCalibre™’s patent-protected Neuro-Logic AI assets across Solar Drone’s long-endurance autonomous flight platforms. This announcement follows two milestone achievements: the April 10, 2026 acquisition of 100% of the xCalibre™ AI video intelligence IP portfolio...

BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love, Esq., President and Chief Executive Officer, will present at the Bank of America Securities Health Care Conference 2026 on Wednesday, May 13, 2026 at 11:20 a.m. PT. A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. About Annexon Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted immunotherapies for nearly 10 million...

NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB) (“IN8bio” or the “Company”), a clinical-stage biopharmaceutical company developing innovative gamma-delta (“γδ”) T cell therapies for cancer and autoimmune diseases, today announced a series of presentations at leading medical and scientific conferences in May and June 2026, including new clinical data at the American Society of Clinical Oncology (ASCO) Annual Meeting. IN8bio will also host a Research and Development (R&D) Day on May 21, 2026, showcasing advances across its γδ T cell pipeline, including its novel T cell engager (TCE) and clinical γδ T cell therapy programs. “We look forward to sharing progress across our γδ T cell platforms at our R&D Day and several key meetings this quarter,” said William Ho, Chief Executive Officer and Co-Founder...

BOSTON, May 06, 2026 (GLOBE NEWSWIRE) — Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not addressed by existing platform technologies, today announced that Matthew Roden, Ph.D., President and Chief Executive Officer of Aktis Oncology, will present at the BofA Securities Health Care Conference in Las Vegas, Nevada. The presentation will take place on Wednesday, May 13, 2026, at 10:00 a.m. PT. A live webcast of the presentations may be accessed via the Investors section of the Aktis website at investors.aktisoncology.com. An archived replay of the event will be available on the website for approximately 90 days following the conference. About Aktis’ miniprotein radioconjugate...

Angled View of the Cider duplexThe Cider features professional landscaping with beautiful stone exterior.WINSTON-SALEM, N.C., May 06, 2026 (GLOBE NEWSWIRE) — LGI Homes, Inc. (NASDAQ: LGIH) is proud to introduce Cider Hill, an exclusive new townhome community with homes starting in the $350s, now available in the thriving Winston-Salem market. With only 36 homesites available, Cider Hill offers homebuyers a rare opportunity to enjoy low-maintenance living in one of the Triad’s most desirable locations. “Winston-Salem continues to attract homebuyers seeking strong employment opportunities, convenient access throughout the Triad, and a high quality of life,” said Tyler Zulli, Vice President of Sales at LGI Homes. “As the area continues to grow, we’re excited to introduce Cider Hill and offer thoughtfully designed townhomes...

New tool validates SteelPhalt’s commitment to reducing road-laying carbon footprint, providing clear, comparable data for its products to current and potential customersSteelPhaltSteelPhalt™ Announces Environmental Product Declaration ToolROTHERHAM, United Kingdom, May 06, 2026 (GLOBE NEWSWIRE) — SteelPhalt, a business within Harsco Environmental’s ecoproducts™ line and a leader in sustainable asphalt solutions, today announced the launch of its environmental product declaration (EPD) tool and the verification of the process for generating product-specific declarations under the International EPD System. EPDs are a globally recognized and standardized system, developed under the world’s leading program for environmental declaration. They transparently quantify and communicate the environmental impacts of...

Reaffirmed FDA alignment on TSHA-102 BLA pathway, including pivotal trial design, endpoints and potential to submit for approval based on REVEAL pivotal trial 6-month interim analysis, following recent breakthrough therapy Type B meeting Further advanced dosing in the REVEAL pivotal trial, with enrollment in the ASPIRE trial ongoing across multiple sites; on track to complete dosing in REVEAL and ASPIRE in Q2 2026 Maintained favorable tolerability profile with no treatment-related SAEs or DLTs in REVEAL Phase 1/2 and REVEAL pivotal trials as of May 2026 data cutoff; plan to present longer-term safety and efficacy data from Part A of REVEAL Phase 1/2 trials in Q2 2026 Initiated BLA-enabling PPQ campaign for TSHA-102 in April 2026; completion expected in Q4 2026 Conference call and webcast today at 8:30 AM ET DALLAS,...

Vancouver, BC, May 06, 2026 (GLOBE NEWSWIRE) — Apogee Minerals Ltd. (“Apogee” or the “Company” or the “Optionee”) (TSXV: APMI) announces that, further to its news release dated April 27, 2026, it has closed a non-brokered private placement financing of 54,875,000 units at a price of $0.05 per unit (the “Units”) for gross proceeds of $2,743,750 (the “Offering”). Each Unit consists of one common share and one transferrable common share purchase warrant (a “Warrant”). Each Warrant entitles the holder thereof to purchase one additional common share in the capital of the Company at $0.075 per share for four (4) years from the date of issue. In connection with the closing of the Offering, the Company paid $1,600 to an arm’s-length finder. The use of proceeds from the Offering will be used for general working capital and exploration expenditures...